Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials
Search Refinements
Search Results: Clinical Trials
1-15 of 4990 results
bluebird unveils topline interim data from Starbeam study of Lenti-D in CALD
bluebird bio has released topline interim data from the initial cohort of 17 patients in the ongoing Phase 2/3 Starbeam Study (ALD-102) evaluating its investigational gene therapy Lenti-D in under-18 boys with cerebral adrenoleukodystrophy (CALD).
Contract Research & Services > Clinical Trials > News
Roche's emicizumab shows substantial reduction in bleeds in phase III studies
By PBR Staff Writer
Roche’s haemophilia A drug emicizumab has showed a significant effect in the phase III Haven 1 and Haven 2 studies.
Contract Research & Services > Clinical Trials > News
Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017
Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London on 28th & 29th June 2017.
Contract Research & Services > Clinical Trials > Press Releases
Novartis’ heart drug canakinumab meets primary endpoint in phase III study
By PBR Staff Writer
Novartis’ heart drug ACZ885 (canakinumab) has met primary endpoint in the global phase III Canakinumab anti-inflammatory thrombosis outcomes (Cantos) study.
Contract Research & Services > Clinical Trials > News
GSK’s shingles vaccine Shingrix succeeds in phase 3 revaccination trial
By PBR Staff Writer
GSK’s shingles vaccine candidate Shingrix (HZ/su) met its primary objective of inducing a strong immune response in older patients in a phase 3 revaccination trial.
Contract Research & Services > Clinical Trials > News
ImmunoCellular to suspend patient randomization in ICT-107 phase 3 trial
ImmunoCellular Therapeutics has provided an update on the strategic review of its financing and development strategies for ICT-107, its patient-specific, dendritic cell-based immunotherapy for patients with newly diagnosed glioblastoma.
Contract Research & Services > Clinical Trials > News
Pfizer initiates phase 1 study of streptococcus vaccine
Pfizer has commenced a phase 1 trial in healthy volunteers of PF-06760805, an investigational vaccine for the prevention of Group B Streptococcus (GBS) infection.
Contract Research & Services > Clinical Trials > News
Seattle Genetics scraps leukemia drug trial over safety concerns
By PBR Staff Writer
Seattle Genetics has suspended its phase 3 acute myeloid leukemia (AML) trial of vadastuximab talirine (SGN-CD33A) due to a higher rate of death incidents.
Contract Research & Services > Clinical Trials > News
Novartis' Cosentyx generates positive data in ankylosing spondylitis and psoriatic arthritis
By PBR Staff Writer
Novartis' Cosentyx has demonstrated sustained improvements in signs and symptoms for both active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA) in up to 80% of patients at three years.
Contract Research & Services > Clinical Trials > News
Regulus to discontinue clinical development of HCV candidate RG-101
By PBR Staff Writer
Regulus Therapeutics said it intends to discontinue clinical development of RG-101, a microRNA treatment for hepatitis C.
Contract Research & Services > Clinical Trials > News
Probiodrug unveils encouraging results of phase 2a SAPHIR study in AD patients
Probiodrug has reported positive results for its PQ912 candidate in a Phase 2a SAPHIR study in early Alzheimer’s disease (AD) patients.
Contract Research & Services > Clinical Trials > News
Merck and Pfizer's ertugliflozin meets primary endpoints in two type 2 diabetes studies
Merck, in partnership with Pfizer, announced that two phase 3 studies of ertugliflozin, an investigational oral SGLT-2 inhibitor in development to help enhance glycemic control in adults with type 2 diabetes, met their primary endpoints.
Contract Research & Services > Clinical Trials > News
AbbVie's rheumatoid arthritis drug succeeds in phase 3 study
By PBR Staff Writer
AbbVie's Upadacitinib (ABT-494) has met all primary and ranked secondary endpoints in a phase 3 trial in rheumatoid arthritis (RA).
Contract Research & Services > Clinical Trials > News
Teva's migraine candidate fremanezumab succeeds in second phase III study
Teva Pharmaceutical Industries’ Fremanezumab has meets all primary & secondary endpoints across both monthly and quarterly dosing regimens in phase III study in episodic migraine prevention.
Contract Research & Services > Clinical Trials > News
Woodley Equipment Company is Exhibiting at DIA 2017 Annual Meeting
Woodley Equipment Company the Leading Global Provider of Equipment Solutions to the Clinical Trials Industry is Exhibiting Booth #1845 at DIA 2017 Annual Meeting.
Contract Research & Services > Clinical Trials > Press Releases

PBR Supplier Recommendations

CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.... Contract Research & Services > Clinical Trials > Suppliers
CRFweb... from Clindox, Suppliers of Clinical Trial Software
CRFweb is the groundbreaking eCRF application brought to you by Clindox. It sets new standards in web-based, clinical trial software. The combination of a comprehensive feature set, incredibly quick set-up time, simplicity of use and flexible pricing means no trial is too large or too small to be practical. The whole process is genuinely DIY, allowing trial managers to really take control of their trial. ... Contract Research & Services > Clinical Trials > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Contract Research & Services > Clinical Trials > Suppliers
Vaisala - Supplier of Continuous Monitoring Systems for Controlled Life Science Environments
Vaisala is a world leader in environmental and industrial measurement systems and instrumentation. We offer measurement instrumentation, continuous monitoring systems and validation systems to measure and supervise environmental conditions, within regulated or controlled life science environments.... Contract Research & Services > Clinical Trials > Suppliers
Quintiles - Bringing People and Knowledge Together for a Healthier World
Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment.... Contract Research & Services > Clinical Trials > Suppliers
See more

PBR White Paper Recommendations

Softigel introduces new energy gummies at vitafoods By Softigel pbr
Who hasn´t needed a wake-me-up in the morning or hasn´t dragged a tired body to the end of the day? Regardless how we individually spend our day, the intensity of our routine, the sports practice or the stressful of our labor; the common consequence is the high demand and lack of energy.... Contract Research & Services > Clinical Trials > White Papers A Survival Guide to Temperature Data in Life Sciences, by Almac By Almac
Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)1 as well as Good Distribution Practices Supply Chain Integrity2 has made the most significant impact. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire supply chain. The industry is facing stricter compliance demands from regulations and regulatory agencies are not always given clear guidance.... Contract Research & Services > Clinical Trials > White Papers Almac: Changing the Dynamics of Temperature Controlled Shipping Solutions By Almac
In the typical clinical trial today, the cost of shipping and distributing supplies accounts for approximately 60 percent of the overall clinical supply chain. And when the cost of product spoilage from temperature excursions is added into the mix, it is no wonder that pharmaceutical companies, Clinical Research Organizations (CROs), and logistics vendors are all eagerly searching for efficiencies and ways to carve costs out of the process.... Contract Research & Services > Clinical Trials > White Papers Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.... Contract Research & Services > Clinical Trials > White Papers Almac Presents Modern Perspectives on Peptide Synthesis, an Introduction By Almac
The complexity of synthetic peptide products, whether as reagents used in research or as therapeutic APIs, is increasing. As researchers understand more about the biochemical systems which are targeted, and invent ever more sophisticated products, manufacturing methods must keep pace. We look in this article at a number of challenging product classes, the specific problems they present, and potential solutions: Long peptides; Multi-peptide cocktails; Site-specifically modified products.... Contract Research & Services > Clinical Trials > White Papers See more
1-15 of 4990 results